The remission status of AML patients after allo-HCT is associated with a distinct single-cell bone marrow T-cell signature

Acute myeloid leukemia (AML) is a hematologic malignancy for which allogeneic hematopoietic cell transplantation (allo-HCT) often remains the only curative therapeutic approach. However, incapability of T cells to recognize and eliminate residual leukemia stem cells might lead to an insufficient gra...

Full description

Saved in:
Bibliographic Details
Main Authors: Mathioudaki, Anna (Author) , Wang, Xizhe (Author) , Sedloev, David (Author) , Huth, Richard (Author) , Kamal, Aryan (Author) , Hundemer, Michael (Author) , Liu, Yi (Author) , Vasileiou, Spyridoula (Author) , Lulla, Premal (Author) , Müller-Tidow, Carsten (Author) , Dreger, Peter (Author) , Luft, Thomas (Author) , Sauer, Tim (Author) , Schmitt, Michael (Author) , Zaugg, Judith B. (Author) , Pabst, Caroline (Author)
Format: Article (Journal)
Language:English
Published: March 28 2024
In: Blood
Year: 2024, Volume: 143, Issue: 13, Pages: 1269-1281
ISSN:1528-0020
DOI:10.1182/blood.2023021815
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1182/blood.2023021815
Get full text
Author Notes:Anna Mathioudaki, Xizhe Wang, David Sedloev, Richard Huth, Aryan Kamal, Michael Hundemer, Yi Liu, Spyridoula Vasileiou, Premal Lulla, Carsten Müller-Tidow, Peter Dreger, Thomas Luft, Tim Sauer, Michael Schmitt, Judith B. Zaugg, and Caroline Pabst

MARC

LEADER 00000caa a2200000 c 4500
001 1908735740
003 DE-627
005 20251104092613.0
007 cr uuu---uuuuu
008 241115s2024 xx |||||o 00| ||eng c
024 7 |a 10.1182/blood.2023021815  |2 doi 
035 |a (DE-627)1908735740 
035 |a (DE-599)KXP1908735740 
035 |a (OCoLC)1475647468 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Mathioudaki, Anna  |d 1994-  |e VerfasserIn  |0 (DE-588)1309238014  |0 (DE-627)1869915445  |4 aut 
245 1 4 |a The remission status of AML patients after allo-HCT is associated with a distinct single-cell bone marrow T-cell signature  |c Anna Mathioudaki, Xizhe Wang, David Sedloev, Richard Huth, Aryan Kamal, Michael Hundemer, Yi Liu, Spyridoula Vasileiou, Premal Lulla, Carsten Müller-Tidow, Peter Dreger, Thomas Luft, Tim Sauer, Michael Schmitt, Judith B. Zaugg, and Caroline Pabst 
264 1 |c March 28 2024 
300 |b Illustrationen 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 15.11.2024 
520 |a Acute myeloid leukemia (AML) is a hematologic malignancy for which allogeneic hematopoietic cell transplantation (allo-HCT) often remains the only curative therapeutic approach. However, incapability of T cells to recognize and eliminate residual leukemia stem cells might lead to an insufficient graft-versus-leukemia (GVL) effect and relapse. Here, we performed single-cell RNA-sequencing (scRNA-seq) on bone marrow (BM) T lymphocytes and CD34+ cells of 6 patients with AML 100 days after allo-HCT to identify T-cell signatures associated with either imminent relapse (REL) or durable complete remission (CR). We observed a higher frequency of cytotoxic CD8+ effector and gamma delta (γδ) T cells in CR vs REL samples. Pseudotime and gene regulatory network analyses revealed that CR CD8+ T cells were more advanced in maturation and had a stronger cytotoxicity signature, whereas REL samples were characterized by inflammatory tumor necrosis factor/NF-κB signaling and an immunosuppressive milieu. We identified ADGRG1/GPR56 as a surface marker enriched in CR CD8+ T cells and confirmed in a CD33-directed chimeric antigen receptor T cell/AML coculture model that GPR56 becomes upregulated on T cells upon antigen encounter and elimination of AML cells. We show that GPR56 continuously increases at the protein level on CD8+ T cells after allo-HCT and confirm faster interferon gamma (IFN-γ) secretion upon re-exposure to matched, but not unmatched, recipient AML cells in the GPR56+ vs GPR56- CD8+ T-cell fraction. Together, our data provide a single-cell reference map of BM-derived T cells after allo-HCT and propose GPR56 expression dynamics as a surrogate for antigen encounter after allo-HCT. 
700 1 |a Wang, Xizhe  |d 1993-  |e VerfasserIn  |0 (DE-588)1366071522  |0 (DE-627)1926016491  |4 aut 
700 1 |a Sedloev, David  |e VerfasserIn  |0 (DE-588)1252255403  |0 (DE-627)1793382204  |4 aut 
700 1 |a Huth, Richard  |e VerfasserIn  |4 aut 
700 1 |a Kamal, Aryan  |d 1992-  |e VerfasserIn  |0 (DE-588)1380619246  |0 (DE-627)1940092035  |4 aut 
700 1 |a Hundemer, Michael  |d 1972-  |e VerfasserIn  |0 (DE-588)128390549  |0 (DE-627)372634001  |0 (DE-576)297117998  |4 aut 
700 1 |a Liu, Yi  |e VerfasserIn  |0 (DE-588)1164192132  |0 (DE-627)1028654979  |0 (DE-576)508429986  |4 aut 
700 1 |a Vasileiou, Spyridoula  |e VerfasserIn  |4 aut 
700 1 |a Lulla, Premal  |e VerfasserIn  |4 aut 
700 1 |a Müller-Tidow, Carsten  |d 1968-  |e VerfasserIn  |0 (DE-588)1015101798  |0 (DE-627)705330230  |0 (DE-576)351197893  |4 aut 
700 1 |a Dreger, Peter  |e VerfasserIn  |0 (DE-588)1028891881  |0 (DE-627)732699894  |0 (DE-576)376320966  |4 aut 
700 1 |a Luft, Thomas  |e VerfasserIn  |0 (DE-588)1078976309  |0 (DE-627)839996969  |0 (DE-576)452120659  |4 aut 
700 1 |a Sauer, Tim  |d 1981-  |e VerfasserIn  |0 (DE-588)138282013  |0 (DE-627)601099516  |0 (DE-576)307058166  |4 aut 
700 1 |a Schmitt, Michael  |d 1966-  |e VerfasserIn  |0 (DE-588)133177173  |0 (DE-627)538000600  |0 (DE-576)299672921  |4 aut 
700 1 |a Zaugg, Judith B.  |e VerfasserIn  |4 aut 
700 1 |a Pabst, Caroline  |d 1981-  |e VerfasserIn  |0 (DE-588)136164668  |0 (DE-627)577203819  |0 (DE-576)284653667  |4 aut 
773 0 8 |i Enthalten in  |t Blood  |d Washington, DC : American Society of Hematology, 1946  |g 143(2024), 13 vom: März, Seite 1269-1281  |h Online-Ressource  |w (DE-627)266886647  |w (DE-600)1468538-3  |w (DE-576)075961938  |x 1528-0020  |7 nnas  |a The remission status of AML patients after allo-HCT is associated with a distinct single-cell bone marrow T-cell signature 
773 1 8 |g volume:143  |g year:2024  |g number:13  |g month:03  |g pages:1269-1281  |g extent:13  |a The remission status of AML patients after allo-HCT is associated with a distinct single-cell bone marrow T-cell signature 
856 4 0 |u https://doi.org/10.1182/blood.2023021815  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20241115 
993 |a Article 
994 |a 2024 
998 |g 136164668  |a Pabst, Caroline  |m 136164668:Pabst, Caroline  |d 910000  |d 910100  |e 910000PP136164668  |e 910100PP136164668  |k 0/910000/  |k 1/910000/910100/  |p 16  |y j 
998 |g 133177173  |a Schmitt, Michael  |m 133177173:Schmitt, Michael  |d 910000  |d 910100  |e 910000PS133177173  |e 910100PS133177173  |k 0/910000/  |k 1/910000/910100/  |p 14 
998 |g 138282013  |a Sauer, Tim  |m 138282013:Sauer, Tim  |d 910000  |d 910100  |e 910000PS138282013  |e 910100PS138282013  |k 0/910000/  |k 1/910000/910100/  |p 13 
998 |g 1078976309  |a Luft, Thomas  |m 1078976309:Luft, Thomas  |d 910000  |d 910100  |d 50000  |e 910000PL1078976309  |e 910100PL1078976309  |e 50000PL1078976309  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 12 
998 |g 1028891881  |a Dreger, Peter  |m 1028891881:Dreger, Peter  |d 910000  |d 910100  |e 910000PD1028891881  |e 910100PD1028891881  |k 0/910000/  |k 1/910000/910100/  |p 11 
998 |g 1015101798  |a Müller-Tidow, Carsten  |m 1015101798:Müller-Tidow, Carsten  |d 910000  |d 910100  |e 910000PM1015101798  |e 910100PM1015101798  |k 0/910000/  |k 1/910000/910100/  |p 10 
998 |g 1164192132  |a Liu, Yi  |m 1164192132:Liu, Yi  |d 910000  |d 910100  |e 910000PL1164192132  |e 910100PL1164192132  |k 0/910000/  |k 1/910000/910100/  |p 7 
998 |g 128390549  |a Hundemer, Michael  |m 128390549:Hundemer, Michael  |d 910000  |d 910100  |d 50000  |e 910000PH128390549  |e 910100PH128390549  |e 50000PH128390549  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 6 
998 |g 1380619246  |a Kamal, Aryan  |m 1380619246:Kamal, Aryan  |d 140000  |e 140000PK1380619246  |k 0/140000/  |p 5 
998 |g 1252255403  |a Sedloev, David  |m 1252255403:Sedloev, David  |d 910000  |d 910100  |e 910000PS1252255403  |e 910100PS1252255403  |k 0/910000/  |k 1/910000/910100/  |p 3 
998 |g 1366071522  |a Wang, Xizhe  |m 1366071522:Wang, Xizhe  |d 50000  |e 50000PW1366071522  |k 0/50000/  |p 2 
999 |a KXP-PPN1908735740  |e 4615156030 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 15.11.2024"],"recId":"1908735740","id":{"doi":["10.1182/blood.2023021815"],"eki":["1908735740"]},"title":[{"title":"The remission status of AML patients after allo-HCT is associated with a distinct single-cell bone marrow T-cell signature","title_sort":"remission status of AML patients after allo-HCT is associated with a distinct single-cell bone marrow T-cell signature"}],"relHost":[{"corporate":[{"display":"American Society of Hematology","role":"isb","roleDisplay":"Herausgebendes Organ"}],"titleAlt":[{"title":"Blood online"}],"pubHistory":["1.1946 -"],"recId":"266886647","part":{"extent":"13","year":"2024","pages":"1269-1281","text":"143(2024), 13 vom: März, Seite 1269-1281","issue":"13","volume":"143"},"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"publisherPlace":"Washington, DC ; Philadelphia, Pa. ; Stanford, Calif.","dateIssuedKey":"1946","dateIssuedDisp":"1946-","publisher":"American Society of Hematology ; Saunders ; HighWire Press"}],"disp":"The remission status of AML patients after allo-HCT is associated with a distinct single-cell bone marrow T-cell signatureBlood","note":["Gesehen am 21.04.2023"],"id":{"eki":["266886647"],"zdb":["1468538-3"],"issn":["1528-0020"]},"title":[{"title":"Blood","title_sort":"Blood","subtitle":"journal of the American Society of Hematology"}]}],"name":{"displayForm":["Anna Mathioudaki, Xizhe Wang, David Sedloev, Richard Huth, Aryan Kamal, Michael Hundemer, Yi Liu, Spyridoula Vasileiou, Premal Lulla, Carsten Müller-Tidow, Peter Dreger, Thomas Luft, Tim Sauer, Michael Schmitt, Judith B. Zaugg, and Caroline Pabst"]},"person":[{"given":"Anna","display":"Mathioudaki, Anna","role":"aut","roleDisplay":"VerfasserIn","family":"Mathioudaki"},{"roleDisplay":"VerfasserIn","family":"Wang","given":"Xizhe","display":"Wang, Xizhe","role":"aut"},{"roleDisplay":"VerfasserIn","family":"Sedloev","display":"Sedloev, David","role":"aut","given":"David"},{"roleDisplay":"VerfasserIn","family":"Huth","role":"aut","display":"Huth, Richard","given":"Richard"},{"family":"Kamal","roleDisplay":"VerfasserIn","display":"Kamal, Aryan","role":"aut","given":"Aryan"},{"roleDisplay":"VerfasserIn","family":"Hundemer","display":"Hundemer, Michael","role":"aut","given":"Michael"},{"roleDisplay":"VerfasserIn","family":"Liu","role":"aut","display":"Liu, Yi","given":"Yi"},{"family":"Vasileiou","roleDisplay":"VerfasserIn","display":"Vasileiou, Spyridoula","role":"aut","given":"Spyridoula"},{"display":"Lulla, Premal","role":"aut","given":"Premal","family":"Lulla","roleDisplay":"VerfasserIn"},{"given":"Carsten","display":"Müller-Tidow, Carsten","role":"aut","family":"Müller-Tidow","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Dreger, Peter","given":"Peter","family":"Dreger","roleDisplay":"VerfasserIn"},{"given":"Thomas","display":"Luft, Thomas","role":"aut","roleDisplay":"VerfasserIn","family":"Luft"},{"given":"Tim","display":"Sauer, Tim","role":"aut","roleDisplay":"VerfasserIn","family":"Sauer"},{"given":"Michael","role":"aut","display":"Schmitt, Michael","roleDisplay":"VerfasserIn","family":"Schmitt"},{"role":"aut","display":"Zaugg, Judith B.","given":"Judith B.","roleDisplay":"VerfasserIn","family":"Zaugg"},{"family":"Pabst","roleDisplay":"VerfasserIn","role":"aut","display":"Pabst, Caroline","given":"Caroline"}],"physDesc":[{"noteIll":"Illustrationen","extent":"13 S."}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"March 28 2024","dateIssuedKey":"2024"}],"language":["eng"]} 
SRT |a MATHIOUDAKREMISSIONS2820